Navigation Links
MicroDose and Nexus6 Announce Collaboration to Evaluate Application of Remote Patient Compliance Monitoring Technology with MicroDose's Electronic Dry Powder Inhaler
Date:1/6/2009

MONMOUTH JUNCTION, N.J. and AUCKLAND, New Zealand, Jan. 6 /PRNewswire/ -- MicroDose Technologies, Inc. (MicroDose) and Nexus6 today announced that they have entered into a collaboration to investigate the application of Nexus6's SmartinhalerLive(TM) technology with MicroDose's next generation electronic dry powder inhaler (DPI). Under the terms of the agreement, MicroDose will fund the development of prototypes based upon MicroDose's inhaler platform and incorporating Nexus6's SmartinhalerLive(TM) technology. MicroDose will receive an option for an exclusive license to the SmartinhalerLive(TM) platform for certain fields of use.

(Logo: http://www.newscom.com/cgi-bin/prnh/20070803/NYF045LOGO )

The aim of the investigation is to demonstrate the ability to wirelessly upload dosing and compliance information from the inhaler to a web-based server for data management and reporting. The SmartinhalerLive technology, providing global roaming wireless, is a natural extension of MicroDose's electronic inhaler features and will facilitate better communication between the physician, patient and pharmaceutical company to improve all aspects of care.

The combined system would have benefits in both the clinical trials setting and with in-market products. By improving compliance through reminder features, and through real-time tracking of compliance, patient safety and clinical trial data management are improved. Improved control and monitoring of compliance can significantly reduce the number of patients enrolled per Phase II or Phase III clinical studies. In marketed products, the system represents a move to more personalized care, giving a better understanding of drug usage and patient response to therapy, and improved compliance and adherence.

Mr. Michael J. Martin VP of Business Development and Licensing of Micro
'/>"/>

SOURCE MicroDose Technologies, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Horizon Therapeutics Announces Senior Management Appointments
2. BioSpecifics Technologies Corp. Announces Listing on NASDAQ Global Market
3. Star Scientific Announces Successful Completion of Product Satisfaction Study - Results Show Potential for Development and Manufacturing of New Pharmaceutical Product for Smoking and Smokeless Tobacco Cessation
4. ADVENTRX Announces Further Cost-Cutting Measures
5. Health Robotics Announces Results of the European Union-Sponsored SafeChemo Project
6. West Penn Allegheny Health System Announces Recruitment of Leading Burn Specialists
7. Nektar Announces Closing of Sale of Specific Pulmonary Delivery Assets to Novartis for $115 Million
8. Medical Machines Online Announces Release of a Brand New Philips HeartStart AED Defibrillator
9. Health Robotics Announces Partnership in the Peoples Republic of China With The Devon International Group
10. Rosetta Genomics Announces Commercial Availability of Its Third MicroRNA-Based Diagnostic Test: miRview(TM) meso
11. Video: Allergan Announces U.S. Food and Drug Administration (FDA) Approval of Latisse(TM) -- First and Only Treatment Approved by the FDA for Hypotrichosis of Eyelashes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/10/2014)... new study published today in the journal PNAS ... found that time of day and sleep deprivation have ... be crucial when looking at the best time of ... heart disease, and for administering medicines effectively. , Researchers ... Cancer Research, London, investigated the links between sleep deprivation, ...
(Date:7/10/2014)... out for crude 3-D glasses, polarized glasses, and ... basic devices, used to trick the brain into ... rendered obsolete with the introduction of new holography ... TAU doctoral students Yuval Yifat, Michal Eitan, and ... on nanoantennas that could be used for security ...
(Date:1/15/2014)...  Bill Jacobs Automotive, a group of car dealerships headquartered in ... Heartland Blood Center and offering free oil change coupons for ... Saturday, Jan. 18 at the Bill Jacobs Cadillac and Chevrolet ... http://photos.prnewswire.com/prnh/20140115/MN46637 )  The Bill Jacobs Auto ...
(Date:1/15/2014)... OXFORD, England and SAN JOSE, California ... an international biotechnology company developing antibody-drug conjugates for cancer, today ... its Board of Directors. Dr Reynolds has over 20 years, ... Chief Medical Officer at Seattle Genetics. "I am ...
Breaking Biology Technology:Time of day crucial to accurately test for diseases, new research finds 2Projecting a 3-dimensional future 2Projecting a 3-dimensional future 3Join the Bill Jacobs Auto blood drive and receive a free oil change 2Oxford BioTherapeutics Appoints Thomas C Reynolds MD, PhD to its Board of Directors 2Oxford BioTherapeutics Appoints Thomas C Reynolds MD, PhD to its Board of Directors 3
... Purpose , ... of protease inhibitor (PI) and non-nucleoside reverse transcriptase inhibitor (NNRTI) ... of assessing inter-individual and intra-individual metabolism variability. To be of ... to monitor these drugs is fast and easy to perform, ...
... Introduction , ... products are radioactively labeled using either endlabeled primers or ... Successful sequencing results produced by these two labeling methods ... breaks, impurities or high secondary structure can cause DNA ...
... , Researchers and forensic agencies that test samples or ... These assays suffer from a number of limitations: , ... not as commonly available for novel sample matrices such as saliva as they are for ... be relatively costly due to the high volume of reagents used. , ...
Cached Biology Technology:A simple and rapid LC-MS/MS method for the simultaneous determination of nine antiretroviral drugs commonly used in Europe (protease Inhibitors and non-nucleoside reverse transcriptase inhibitors) 2A simple and rapid LC-MS/MS method for the simultaneous determination of nine antiretroviral drugs commonly used in Europe (protease Inhibitors and non-nucleoside reverse transcriptase inhibitors) 3A simple and rapid LC-MS/MS method for the simultaneous determination of nine antiretroviral drugs commonly used in Europe (protease Inhibitors and non-nucleoside reverse transcriptase inhibitors) 4A simple method to sequence from bacterial colonies using [a-33P] radiolabeled ddNTPs and Thermo Sequenase 2A simple method to sequence from bacterial colonies using [a-33P] radiolabeled ddNTPs and Thermo Sequenase 3Simultaneous Screening of 23 Drugs of Abuse in Oral Fluid Using an LC/MS/MS Method 2Simultaneous Screening of 23 Drugs of Abuse in Oral Fluid Using an LC/MS/MS Method 3Simultaneous Screening of 23 Drugs of Abuse in Oral Fluid Using an LC/MS/MS Method 4
(Date:7/10/2014)... known as heme enzymes, due to the presence of ... centre of the heme cofactor is an iron (Fe) ... is in an intermediate state called Compound I. The ... this oxidation involves just an oxygen atom (O), or ... implications for understanding oxidative processes within living cells, which ...
(Date:7/10/2014)... HOUSTON (July 10, 2014) New research from ... (UTHealth) shows that It,s Your GameKeep it Real (IYG), ... and promote healthy dating relationships, can significantly reduce dating ... Centers for Disease Control and Prevention, 10 percent of ... and other studies suggest that more than 20 percent ...
(Date:7/10/2014)... Spanish National Cancer Research Centre (CNIO) Macromolecular Crystallography ... a protein called BuD to DNA in order ... Montoya, the researcher who led the study, says ... edit the instructions contained in the genome to ... The study is published in the journal ...
Breaking Biology News(10 mins):Neutron crystallography solves long-standing biological mystery 2Neutron crystallography solves long-standing biological mystery 3It's Your Game ... Keep It Real reduces dating violence among minority youth 2CNIO scientists develop technology to redirect proteins towards specific areas of the genome 2
... Varanus komodoensis ) are known to bite prey and release ... the victims are reported to go into shock before the ... prey are killed by pathogenic bacteria in the dragons, mouths ... of Proceedings of the National Academy of Sciences ...
... active site found in a naturally occurring enzyme, chemists at ... like nature,s most pervasive hydrogen processor. , The researchers describe ... Journal of the American Chemical Society , and posted ... puzzled by nature,s ability to use cheap and plentiful building ...
... million cases of malaria are diagnosed each year mostly ... treat malaria do exist, the demand for new treatments ... have developed a resistance to existing medications. Now, ... have discovered one way to stop malaria parasite growth, ...
Cached Biology News:Komodo even more deadly than thought: Research 2New lead on malaria treatment 2
HyPro 20 system for slide hybridization. 20 slide capacity. Active vibration system, slide rack and humidity chamber. Ideal for microarray and in situ hybridization....
... PBL's bioassays for interferons are cytopathic effect inhibition ... Sample types include; tissue culture supernatents; serum ... these assays, one unit is defined as the ... the cytopathic effect of viral infection by 50%. ...
Request Info...
Request Info...
Biology Products: